The BALANCE Study: A Study in Spain to Find Out Whether a Patient Support Program Helps People With Pulmonary Fibrosis Who Take Nintedanib

RecruitingOBSERVATIONAL
Enrollment

493

Participants

Timeline

Start Date

June 23, 2025

Primary Completion Date

December 23, 2026

Study Completion Date

December 23, 2026

Conditions
Pulmonary Fibrosis
Trial Locations (1)

08005

RECRUITING

Evidenze Health España S.L.U, Barcelona

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT06912659 - The BALANCE Study: A Study in Spain to Find Out Whether a Patient Support Program Helps People With Pulmonary Fibrosis Who Take Nintedanib | Biotech Hunter | Biotech Hunter